Ten-Year Response to Crizotinib in ALK-positive Inflammatory Myofibroblastic Tumors: Case Reports. Вопр. онкол. [Internet]. 2024 May 6 [cited 2026 Oct. 14];70(2):384-9. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/2-24-Ten-Year